BlackRock
XTNT icon

BlackRock’s Xtant Medical Holdings XTNT Stock Holding History

BlackRock’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.6K Hold
115,782
– – ﹤0.01% 5064
2025
Q4 		$90.8K Sell
115,782
-4,544
-4% -$3.3K ﹤0.01% 4926
2025
Q3 		$78.1K Hold
120,326
– – ﹤0.01% 4895
2025
Q2 		$88.9K Hold
120,326
– – ﹤0.01% 4868
2025
Q1 		$56.6K Hold
120,326
– – ﹤0.01% 4892
2024
Q4 		$53.3K Hold
120,326
– – ﹤0.01% 4935
2024
Q3 		$81.3K Hold
120,326
– – ﹤0.01% 4715
2024
Q2 		$75.8K Hold
120,326
– – ﹤0.01% 4765
2024
Q1 		$141K Sell
120,326
-135,372
-53% -$148K ﹤0.01% 4662
2023
Q4 		$289K Buy
255,698
+135,229
+112% +$159K ﹤0.01% 4548
2023
Q3 		$133K Buy
120,469
+120,326
+84,144% +$129K ﹤0.01% 4777
2023
Q2 		$133 Hold
143
– – ﹤0.01% 5460
2023
Q1 		$91 Hold
143
– – ﹤0.01% 5534
2022
Q4 		$94 Hold
143
– – ﹤0.01% 5723
2022
Q3 		$0 Hold
143
– – ﹤0.01% 5954
2022
Q2 		$0 Sell
143
-21,842
-99% -$12.9K ﹤0.01% 6012
2022
Q1 		$15K Sell
21,985
-1,098
-5% -$719 ﹤0.01% 5605
2021
Q4 		$13K Buy
23,083
+610
+3% +$575 ﹤0.01% 5589
2021
Q3 		$25K Sell
22,473
-488
-2% -$634 ﹤0.01% 5379
2021
Q2 		$38K Buy
22,961
+22,818
+15,957% +$40.6K ﹤0.01% 5226
2021
Q1 		$0 Hold
143
– – ﹤0.01% 5370
2020
Q4 		$0 Buy
143
+23
+19% +$30 ﹤0.01% 5192
2020
Q3 		$0 Hold
120
– – ﹤0.01% 5187
2020
Q2 		$0 Sell
120
-9,703
-99% -$8.9K ﹤0.01% 5152
2020
Q1 		$6K Sell
9,823
-486
-5% -$587 ﹤0.01% 4762
2019
Q4 		$16K Sell
10,309
-108
-1% -$221 ﹤0.01% 4691
2019
Q3 		$30K Sell
10,417
-594
-5% -$1.65K ﹤0.01% 4599
2019
Q2 		$33K Buy
11,011
+1,363
+14% +$4.19K ﹤0.01% 4634
2019
Q1 		$29K Sell
9,648
-658
-6% -$1.92K ﹤0.01% 4552
2018
Q4 		$16K Sell
10,306
-168
-2% -$542 ﹤0.01% 4610
2018
Q3 		$41K Buy
10,474
+414
+4% +$2.19K ﹤0.01% 4569
2018
Q2 		$56K Buy
10,060
+9,940
+8,283% +$66.5K ﹤0.01% 4545
2018
Q1 		$1K Sell
120
-1
-0.8% -$7 ﹤0.01% 4890
2017
Q4 		$1K Hold
121
– – ﹤0.01% 4896
2017
Q3 		$1K Hold
121
– – ﹤0.01% 4929
2017
Q2 		$1K Hold
121
– – ﹤0.01% 4983
2017
Q1 		$1K Buy
+121
New +$744 ﹤0.01% 4970

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock's XTNT Position: Q1 2026 in Review

BlackRock held its Xtant Medical Holdings (XTNT) position steady in Q1 2026 at 115,782 shares worth $64.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5064.

BlackRock first reported a position in XTNT in Q1 2017 and has held it in 37 quarters since. The position peaked at $289K in Q4 2023. 34 funds tracked by Wall St. Rank hold XTNT as of Q1 2026.

  • BlackRock held 115,782 shares of Xtant Medical Holdings worth $64.6K as of Q1 2026.
  • BlackRock left its Xtant Medical Holdings share count unchanged in Q1 2026.
  • Xtant Medical Holdings made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5064 holding.
  • BlackRock first reported a position in Xtant Medical Holdings in Q1 2017 and has held it in 37 quarters since.
  • BlackRock's Xtant Medical Holdings position peaked at $289K in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.